List of bibliographic references indexed by blind
Number of relevant bibliographic references: 8.
| Ident. | Authors (with country if any) | Title |
|---|
| 000134 (2021) |
Fatemeh Roozbeh [Iran] ; Majid Saeedi [Iran] ; Reza Alizadeh-Navaei [Iran] ; Akbar Hedayatizadeh-Omran [Iran] ; Shahin Merat [Iran] ; Hannah Wentzel [Royaume-Uni] ; Jacob Levi [Royaume-Uni] ; Andrew Hill [Royaume-Uni] ; Amir Shamshirian [Iran] | Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial. |
| 000429 (2021) |
Vincent Dubée [France] ; Pierre-Marie Roy [France] ; Bruno Vielle [France] ; Elsa Parot-Schinkel [France] ; Odile Blanchet [France] ; Astrid Darsonval [France] ; Caroline Lefeuvre [France] ; Chadi Abbara [France] ; Sophie Boucher [France] ; Edouard Devaud [France] ; Olivier Robineau [France] ; Patrick Rispal [France] ; Thomas Guimard [France] ; Emma D'Anglejean [France] ; Sylvain Diamantis [France] ; Marc-Antoine Custaud [France] ; Isabelle Pellier [France] ; Alain Mercat [France] | Hydroxychloroquine in mild-to-moderate COVID-19: a placebo-controlled double blind trial. |
| 000524 (2021) |
Amirreza Roostaei Firozabad [Iran] ; Zohreh Akhoundi Meybodi [Iran] ; Seyed Ruhollah Mousavinasab [Iran] ; Adeleh Sahebnasagh [Iran] ; Mohsen Gholinataj Jelodar [Iran] ; Iman Karimzadeh [Iran] ; Solomon Habtemariam [Royaume-Uni] ; Fatemeh Saghafi [Iran] | Efficacy and safety of Levamisole treatment in clinical presentations of non-hospitalized patients with COVID-19: a double-blind, randomized, controlled trial. |
| 000782 (2021) |
Purwati [Indonésie] ; Budiono [Indonésie] ; Brian Eka Rachman [Indonésie] ; Yulistiani [Indonésie] ; Andang Miatmoko [Indonésie] ; Nasronudin [Indonésie] ; Soroy Lardo [Indonésie] ; Yongki Iswandi Purnama [Indonésie] ; Mafidhatul Laely [Indonésie] ; Ike Rochmad [Indonésie] ; Taufik Ismail [Indonésie] ; Sri Wulandari [Indonésie] ; Dwi Setyawan [Indonésie] ; Alfian Nur Rosyid [Indonésie] ; Herley Windo Setiawan [Indonésie] ; Prastuti Asta Wulaningrum [Indonésie] ; Tri Pudy Asmarawati [Indonésie] ; Erika Marfiani [Indonésie] ; Shinta Karina Yuniati [Indonésie] ; Muhammad Rabiul Fuadi [Indonésie] ; Pepy Dwi Endraswari [Indonésie] ; Purwaningsih [Indonésie] ; Eryk Hendrianto [Indonésie] ; Deya Karsari [Indonésie] ; Aristika Dinaryanti [Indonésie] ; Nora Ertanti [Indonésie] ; Igo Syaiful Ihsan [Indonésie] ; Disca Sandyakala Purnama [Indonésie] ; Yuni Indrayani [Indonésie] | A Randomized, Double-Blind, Multicenter Clinical Study Comparing the Efficacy and Safety of a Drug Combination of Lopinavir/Ritonavir-Azithromycin, Lopinavir/Ritonavir-Doxycycline, and Azithromycin-Hydroxychloroquine for Patients Diagnosed with Mild to Moderate COVID-19 Infections. |
| 000A56 (2020) |
Robert J. Ulrich [États-Unis] ; Andrea B. Troxel [États-Unis] ; Ellie Carmody [États-Unis] ; Jaishvi Eapen [États-Unis] ; Martin B Cker [États-Unis] ; Jack A. Dehovitz [États-Unis] ; Prithiv J. Prasad [États-Unis] ; Yi Li [États-Unis] ; Camila Delgado [États-Unis] ; Morris Jrada [États-Unis] ; Gabriel A. Robbins [États-Unis] ; Brooklyn Henderson [États-Unis] ; Alexander Hrycko [États-Unis] ; Dinuli Delpachitra [États-Unis] ; Vanessa Raabe [États-Unis] ; Jonathan S. Austrian [États-Unis] ; Yanina Dubrovskaya [États-Unis] ; Mark J. Mulligan [États-Unis] | Treating COVID-19 With Hydroxychloroquine (TEACH): A Multicenter, Double-Blind Randomized Controlled Trial in Hospitalized Patients. |
| 000E27 (2020) |
Berta Grau-Pujol [Espagne, Mozambique] ; Daniel Camprubí [Espagne] ; Helena Marti-Soler [Espagne] ; Marc Fernández-Pardos [Espagne] ; Caterina Guinovart [Espagne] ; Jose Mu Oz [Espagne] | Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial. |
| 001509 (2020) |
Antonio Cuadrado-Lavín [Espagne] ; José Manuel Olmos [Espagne] ; José Manuel Cifrian [Espagne] ; Teresa Gimenez [Espagne] ; Marco Antonio Gandarillas [Espagne] ; Mar García-Saiz [Espagne] ; Maria Henar Rebollo [Espagne] ; Victor Martínez-Taboada [Espagne] ; Marcos L Pez-Hoyos [Espagne] ; María Carmen Fari As [Espagne] ; Javier Crespo [Espagne] | Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial. |
| 001973 (2020) |
Jonathan Rilinger [Allemagne] ; Winfried V. Kern [Allemagne] ; Daniel Duerschmied [Allemagne] ; Alexander Supady [Allemagne] ; Christoph Bode [Allemagne] ; Dawid L. Staudacher [Allemagne] ; Tobias Wengenmayer [Allemagne] | A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "blind"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "blind" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= blind
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 |  |
